Organogenesis Holdings, Inc. (ORGO)
1.71
+0.04
(+2.40%)
USD |
NASDAQ |
Aug 25, 10:08
Organogenesis Holdings Total Assets (Quarterly) : 406.45M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 406.45M |
| March 31, 2026 | 519.99M |
| December 31, 2025 | 598.73M |
| September 30, 2025 | 509.83M |
| June 30, 2025 | 461.13M |
| March 31, 2025 | 467.39M |
| December 31, 2024 | 497.89M |
| September 30, 2024 | 446.30M |
| June 30, 2024 | 443.16M |
| March 31, 2024 | 458.48M |
| December 31, 2023 | 460.02M |
| September 30, 2023 | 462.65M |
| June 30, 2023 | 450.31M |
| March 31, 2023 | 446.11M |
| December 31, 2022 | 449.36M |
| September 30, 2022 | 457.27M |
| June 30, 2022 | 456.36M |
| March 31, 2022 | 436.27M |
| December 31, 2021 | 443.26M |
| September 30, 2021 | 370.42M |
| Date | Value |
|---|---|
| June 30, 2021 | 355.56M |
| March 31, 2021 | 319.18M |
| December 31, 2020 | 290.22M |
| September 30, 2020 | 246.43M |
| June 30, 2020 | 216.49M |
| March 31, 2020 | 208.34M |
| December 31, 2019 | 220.69M |
| September 30, 2019 | 174.64M |
| June 30, 2019 | 168.07M |
| March 31, 2019 | 176.45M |
| December 31, 2018 | 163.68M |
| September 30, 2018 | 316.31M |
| June 30, 2018 | 314.98M |
| March 31, 2018 | 313.79M |
| December 31, 2017 | 312.79M |
| September 30, 2017 | 312.06M |
| June 30, 2017 | 311.56M |
| March 31, 2017 | 311.24M |
| December 31, 2016 | 311.44M |
| September 30, 2016 | 0.8219M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| cbdMD, Inc. | 13.15M |
| Guardian Pharmacy Services, Inc. | 443.58M |
| Ironwood Pharmaceuticals, Inc. | 285.13M |
| Verastem, Inc. | 206.51M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 118.31M |
| Shareholders Equity (Quarterly) | 288.13M |
| Debt to Equity Ratio | 0.2324 |
| Current Ratio | 3.516 |
| Net Debt Paydown Yield | -1.56% |